Generex Biotechnology (GNBT) Short Interest Ratio & Short Volume

Short interest is the volume of Generex Biotechnology shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 100 shares of GNBT short. Learn More on Generex Biotechnology's current short interest.

Here is how the short interest of companies in the sector of "medical" compare to Generex Biotechnology: Propanc Biopharma, Inc. (0.01%), Adhera Therapeutics, Inc. (0.00%), Predictive Technology Group, Inc. (0.00%), GelStat Corp. (0.00%), NovAccess Global Inc. (0.00%), CVR Medical Corp. (0.03%), Bruush Oral Care Inc. (77.14%), Todos Medical Ltd. (0.04%), and Invitae Co. (26.15%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.48 billion), Charter Communications, Inc. ($2.85 billion), Twitter, Inc. ($1.89 billion), T. Rowe Price Group, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.77 billion), PG&E Co. ($1.75 billion), Lucid Group, Inc. ($1.58 billion), Rivian Automotive, Inc. ($1.42 billion), Roblox Co. ($1.39 billion), and Williams-Sonoma, Inc. ($1.33 billion). View all of the most shorted stocks.

Short selling GNBT is an investing strategy that aims to generate trading profit from Generex Biotechnology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Generex Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNBT, twice per month. The most recent reporting period available is October, 15 2022.